Publication

In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia

DOI 10.1056/NEJMoa2601283

Phase 1 interim n=35, human PCSK9/LDL signal and ≥1-year follow-up subset.

No news refers to this card yet.

Also in the catalogue

Scales

Identifiers

DOI
10.1056/NEJMoa2601283

Original sources

Details

Journal
N Engl J Med
Year
2026

A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.